TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Novus Scientific AB
Closing information (x1000 EUR)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 1,956 | 1,751 | 1,707 |
Financial expenses | 8 | 0 | 95 |
Earnings before taxes | -534 | -697 | -687 |
EBITDA | -577 | -710 | -592 |
Total assets | 3,404 | 2,829 | 2,534 |
Current assets | 3,120 | 2,530 | 2,245 |
Current liabilities | 3,005 | 2,303 | 2,284 |
Equity capital | 399 | 526 | 250 |
- share capital | 9 | 10 | 10 |
Employees (average) | 16 | 14 | 13 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 11.7% | 18.6% | 9.9% |
Turnover per employee | 122 | 125 | 131 |
Profit as a percentage of turnover | -27.3% | -39.8% | -40.2% |
Return on assets (ROA) | -15.5% | -24.6% | -23.4% |
Current ratio | 103.8% | 109.9% | 98.3% |
Return on equity (ROE) | -133.8% | -132.5% | -274.8% |
Change turnover | 347 | 76 | 426 |
Change turnover % | 22% | 5% | 33% |
Chg. No. of employees | 2 | 1 | -3 |
Chg. No. of employees % | 14% | 8% | -19% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.